OrbiMed’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-301,000
Closed -$6.92M 125
2023
Q1
$6.92M Buy
+301,000
New +$6.92M 0.14% 90
2020
Q2
Sell
-66,909
Closed -$472K 146
2020
Q1
$472K Sell
66,909
-124,300
-65% -$877K 0.01% 135
2019
Q4
$1.35M Buy
+191,209
New +$1.35M 0.02% 122